Cargando…

Successful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in Adults

Multisystem inflammatory syndrome in adults (MIS-A) is a life-threatening disease that can develop weeks after coronavirus disease 2019 (COVID-19). MIS-A symptoms include multiorgan involvement, especially gastrointestinal tract and heart involvement, and Kawasaki disease-like symptoms. We herein re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneko, Shuzo, Zen, Tsuyoshi, Banjoya, Susumu, Nuki, Toshiaki, Hoshimoto, Ainori, Harano, Makiko, Hagiwara, Sou, Imai, Eri, Tsukamoto, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518551/ https://www.ncbi.nlm.nih.gov/pubmed/37316277 http://dx.doi.org/10.2169/internalmedicine.1728-23

Ejemplares similares

Successful peritoneal dialysis for the end-stage kidney disease associated with Prader–Willi syndrome: a case report
por: Anno, Emi, et al.
Publicado: (2019)

Development of IgA vasculitis with severe glomerulonephritis after COVID-19 vaccination: a case report and literature review
por: Sugita, Kohei, et al.
Publicado: (2022)

Granulocyte and monocyte adsorptive apheresis ameliorates sepsis in rats
por: Ma, Shuai, et al.
Publicado: (2017)

Use of granulocyte and monocyte adsorption apheresis in dermatology (Review)
por: Gnesotto, Laura, et al.
Publicado: (2022)

Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis
por: Fujii, Asami, et al.
Publicado: (2017)

Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2023)

Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis
por: Nakamura, Masanao, et al.
Publicado: (2020)

Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
por: Jeon, Seong Ran
Publicado: (2017)

Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China
por: Lai, Ya-Min, et al.
Publicado: (2017)

Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis
por: Yanagisawa, Kazuki, et al.
Publicado: (2019)

Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19
por: Kanekura, Takuro, et al.
Publicado: (2020)

Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease
por: Ozeki, Keiji, et al.
Publicado: (2012)

Infliximab- and Immunosuppressant-Resistant Crohn's Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone
por: Itagaki, Munenori, et al.
Publicado: (2012)

Peripheral Blood CD64 Levels Decrease in Crohn's Disease following Granulocyte and Monocyte Adsorptive Apheresis
por: Chiba, Toshimi, et al.
Publicado: (2011)

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2015)

Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2021)

Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis
por: Tanida, Satoshi, et al.
Publicado: (2020)

Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2023)

Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
por: Yokoyama, Yoko, et al.
Publicado: (2013)

Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
por: Motoya, Satoshi, et al.
Publicado: (2019)

Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis in a Patient with Low Bone Mineral Density Due to Fanconi-Bickel Syndrome
por: Tanaka, Makoto, et al.
Publicado: (2021)

Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
por: Sernicola, Alvise, et al.
Publicado: (2022)

Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study
por: Yamamoto, Takayuki, et al.
Publicado: (2016)

Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease
por: Fukuchi, Takumi, et al.
Publicado: (2014)

Adsorptive Granulocyte/Monocyte Apheresis for the Maintenance of Remission in Patients with Ulcerative Colitis: A Prospective Randomized, Double Blind, Sham-Controlled Clinical Trial
por: Fukunaga, Ken, et al.
Publicado: (2012)

Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study
por: Ueno, Nobuhiro, et al.
Publicado: (2021)

Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future
por: Chen, Xiu-Li, et al.
Publicado: (2020)

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
por: Martínez, Ana Victoria Carro, et al.
Publicado: (2021)

A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis
por: Tominaga, Chiharu, et al.
Publicado: (2015)

Granulocyte and monocyte/macrophage apheresis in paediatric patients with ulcerative colitis: a case series in Spain
por: de Carpi, Javier Martin
Publicado: (2022)

A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis
por: Imai, Eri, et al.
Publicado: (2016)

A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis
por: Imai, Eri, et al.
Publicado: (2016)

Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial
por: Kakimoto, Kazuki, et al.
Publicado: (2020)

Beneficial effect of LDL-apheresis in refractory nephrotic syndrome
por: Muso, Eri
Publicado: (2014)

Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor
por: Tanida, Satoshi, et al.
Publicado: (2023)

Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review
por: Mastronardi, Mauro, et al.
Publicado: (2023)

Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
por: Koroku, Miki, et al.
Publicado: (2022)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome
por: Muso, Eri, et al.
Publicado: (2015)

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease
por: Lindberg, Annelie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_naq6sr5lm4b70mevm8mdtsn14r